FDA 483 OBSERVATION · #82 OF 1,923 MOST-CITED
Plant operations - Precautions
FDA cited this observation 327 times across 311 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.
What this grouping is not
An observation-type page groups FDA’s published citation records. The grouping, the compliance steps and the root causes are SPEQ synthesis, not an FDA classification of any citation, and a count measures what FDA published rather than risk.
What this observation means, and how to comply
SPEQ's practitioner reading of this finding. The regulatory basis is a cited fact; the interpretation, compliance steps, and root causes are SPEQ synthesis — not an FDA classification of the citation.
The plant did not take the general precautions required during operations to ensure food-safety — including using adequate quality-control operations, cleaning and sanitizing utensils and equipment as needed, and running the whole operation so that food is protected against contamination.
Why FDA writes it — These general operating precautions are the umbrella that keeps day-to-day production from drifting into unsafe practice; without them, quality-control gaps and lapses in equipment sanitation compound until contaminated food reaches consumers.
- Implement adequate quality-control operations that ensure food is suitable and that packaging and containers are safe.
- Clean and sanitize equipment and utensils as frequently as necessary to protect against contamination.
- Conduct overall operations under conditions and controls that minimize the potential for microbial growth and contamination.
- Train supervisors and operators on these precautions and verify adherence during production.
- Quality-control checkpoints are informal or undocumented, so no one confirms the general precautions are actually in place.
- Production pressure leads teams to skip cleaning frequency and in-process checks that the operating precautions require.
How to close this finding — and stop it recurring
What this observation is associated with
Firms cited for this observation also appear in FDA compliance actions — warning letters, injunctions, or seizures — at 1× the rate of the average FDA-cited firm (7.7% vs 7.8%), across 311 FEI-matched firms.
This is an association, not causation, and reflects co-occurrence in FDA's records — not a claim that the observation caused or preceded the action.
How FDA worded it — real examples
You did not conduct operations in accordance with adequate sanitation principles and take adequate precautions to ensure that production procedures did not contribute to allergen cross-contact and to contamination.
You did not conduct operations in accordance with adequate sanitation principles and take adequate precautions to ensure that production procedures did not contribute to allergen cross-contact and to contamination.
You did not conduct operations in accordance with adequate sanitation principles.
You did not conduct operations in accordance with adequate sanitation principles.
You did not conduct operations in accordance with adequate sanitation principles.
You did not take adequate precautions to ensure that production procedures did not contribute to allergen cross-contact and to contamination.
Related SPEQ references
Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.
Examples are a representative sample of FDA's published inspection observations. Open the 483 observation explorer →